Friday - March 29, 2024
University of Texas's MD Anderson Cancer: Study Finds High Tumor Mutation Burden Predicts Immunotherapy Response in Some, But Not All, Cancers
March 16, 2021
HOUSTON, Texas, March 16 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on March 15, 2021:

A high rate of genetic mutations within a tumor, known as high tumor mutation burden (TMB), was only useful for predicting clinical responses to immune checkpoint inhibitors in a subset of cancer types, according to a new study led by researchers from The University of Texas MD Anderson Cancer Center.

The findings, published today . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products